Search research articles
Contact Us
Filters
Showing results (291-300 of 316) with videos related to
Page
of 32
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 29, 2012
Clinical significance of tumor-associated inflammatory cells in metastatic neuroblastoma
Shahab Asgharzadeh, Jill A Salo, Lingyun Ji, et al.
The Lancet. Oncology
|
July 30, 2013
Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial
Susan G Kreissman, Robert C Seeger, Katherine K Matthay, et al.
Pediatric Blood & Cancer
|
May 24, 2021
A safety and feasibility trial of <sup>131</sup> I-MIBG in newly diagnosed high-risk neuroblastoma: A Children's Oncology Group study
Brian D Weiss, Gregory Yanik, Arlene Naranjo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 5, 2017
Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting
Julie R Park, Rochelle Bagatell, Susan L Cohn, et al.
Cancer Research
|
June 17, 2006
Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number
Qun Wang, Sharon Diskin, Eric Rappaport, et al.
Radiology
|
May 19, 2011
Guidelines for imaging and staging of neuroblastic tumors: consensus report from the International Neuroblastoma Risk Group Project
Hervé J Brisse, M Beth McCarville, Claudio Granata, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 11, 2016
Impact of Two Measures of Micrometastatic Disease on Clinical Outcomes in Patients with Newly Diagnosed Ewing Sarcoma: A Report from the Children's Oncology Group
Kieuhoa T Vo, Jeremy V Edwards, C Lorrie Epling, et al.
JCO Global Oncology
|
December 23, 2025
Adaptive Clinical Neuroblastoma Risk Groups-Tailoring Treatment in Low- and Middle-Income Countries: An International Neuroblastoma Risk Group Project
Wendy B London, Gabriela Villanueva, Derek Shyr, et al.
Cell Reports
|
March 7, 2024
ALK upregulates POSTN and WNT signaling to drive neuroblastoma
Miller Huang, Wanqi Fang, Alvin Farrel, et al.
Cell Reports
|
August 4, 2023
Polyclonal lymphoid expansion drives paraneoplastic autoimmunity in neuroblastoma
Miriam I Rosenberg, Erez Greenstein, Martin Buchkovich, et al.
Page
of 32
Search research articles
Search
Showing results (291-300 of 316) with videos related to
Sort By:
Page
of 32
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 29, 2012
Clinical significance of tumor-associated inflammatory cells in metastatic neuroblastoma
Shahab Asgharzadeh, Jill A Salo, Lingyun Ji, et al.
The Lancet. Oncology
|
July 30, 2013
Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial
Susan G Kreissman, Robert C Seeger, Katherine K Matthay, et al.
Pediatric Blood & Cancer
|
May 24, 2021
A safety and feasibility trial of <sup>131</sup> I-MIBG in newly diagnosed high-risk neuroblastoma: A Children's Oncology Group study
Brian D Weiss, Gregory Yanik, Arlene Naranjo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 5, 2017
Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting
Julie R Park, Rochelle Bagatell, Susan L Cohn, et al.
Cancer Research
|
June 17, 2006
Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number
Qun Wang, Sharon Diskin, Eric Rappaport, et al.
Radiology
|
May 19, 2011
Guidelines for imaging and staging of neuroblastic tumors: consensus report from the International Neuroblastoma Risk Group Project
Hervé J Brisse, M Beth McCarville, Claudio Granata, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 11, 2016
Impact of Two Measures of Micrometastatic Disease on Clinical Outcomes in Patients with Newly Diagnosed Ewing Sarcoma: A Report from the Children's Oncology Group
Kieuhoa T Vo, Jeremy V Edwards, C Lorrie Epling, et al.
JCO Global Oncology
|
December 23, 2025
Adaptive Clinical Neuroblastoma Risk Groups-Tailoring Treatment in Low- and Middle-Income Countries: An International Neuroblastoma Risk Group Project
Wendy B London, Gabriela Villanueva, Derek Shyr, et al.
Cell Reports
|
March 7, 2024
ALK upregulates POSTN and WNT signaling to drive neuroblastoma
Miller Huang, Wanqi Fang, Alvin Farrel, et al.
Cell Reports
|
August 4, 2023
Polyclonal lymphoid expansion drives paraneoplastic autoimmunity in neuroblastoma
Miriam I Rosenberg, Erez Greenstein, Martin Buchkovich, et al.
Page
of 32